Skip to search formSkip to main contentSkip to account menu

mozavaptan

Known as: N-(4-(((5RS)-5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl)phenyl)-2-methylbenzamide 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

BenzazepinesVasopressin Antagonist

Narrower (2)

OPC 31260mozavaptan hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Bazı Farmakolojik Şaperonların Mutant AVPR2 Proteinlerinde Gözlemlenen Fonksiyon Kayıpları Üzerine Etkilerinin Araştırılması
Protein katlanmasindaki hatalar, anormal ya da olgunlasmamis proteinlerin meydana gelmesine neden olmaktadir. Yanlis katlanmis… 
Review
2013
Review
2013
Vaptans: a novel class of drugs causing free water diuresis
>> We read with interest the recent review on diuretics. 1 The author comprehensively discussed types of diuretics, their… 
2011
2011
Improved synthesis of mozavaptan
Mozavaptan(1),a new type of vasopressin V2 receptor antagonist,has been used for the treatment of hyponatremia caused by heart… 
Review
2008
Review
2008
Treatment of Hyponatremia in Cirrhosis
Letter to the Editor In his review article, Dr. Mahesh [1] discussed the pathophysiology and management of hyponatremia in… 
2006
2006
Mozavaptan close to approval in Japan for hyponatraemia
  • 2006
  • Corpus ID: 195111351
2003
2003
Mozavaptan promising in polycystic kidney disease
  • 2003
  • Corpus ID: 195125789
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)